You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Diagnostic Microarray for West Nile Virus Infections

    SBC: Focus/Mrl, Inc.-Mrl Pharmaceutical Srvs            Topic: N/A

    DESCRIPTION (provided by applicant): Rapid, accurate detection of West Nile virus (WNV) infections can alert public health officials to increase preventative measures and control outbreaks. By applying our novel immobilized particle microarray technology to the detection of antibodies to WNV, and making it compatible with 384-well microplates, chemical kinetic theory predicts we can: 1) eliminate ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  2. Injectable Delivery of Bone Growth Factor, HomoSer3-AIII

    SBC: Fziomed, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): While bone fractures usually heal successfully, a significant number, approaching 300,000 fractures per year in the US, heal slowly or do not heal at all. In addition to these fractures, in the US each year there are approximately 200,000 spinal fusions for lower back pain. Spinal fusions consume over half of all available bone graft substitutes including human ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  3. ORAL AGENTS TO INDUCE FETAL HEMOGLOBIN

    SBC: Gene Regulation Laboratories            Topic: N/A

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  4. Development of a micropump for the glaucomatous eye

    SBC: Glaukos Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Glaucoma is primarily treated by the reduction of intraocular pressure (IOP). After failure of conservative therapy, trabeculectomy with or without antimetabolites is used to lower IOP. Trabeculectomy is a time-consuming surgical procedure that requires significant surgical and post-operative finesse to achieve success. It is subject to a host of complications ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. GRAM+ ANTIMICROBIALS TARGETED TO DNA POLYMERASE III

    SBC: GLSynthesis Inc.            Topic: N/A

    N/A

    STTR Phase I 1998 Department of Health and Human Services
  6. Transgenic Goats Produced by Germ Cell Transplantation

    SBC: GTC BIOTHERAPEUTICS, INC.            Topic: N/A

    N/A

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  7. Nuclear Transfer Embryos from Tetraploid Embryos

    SBC: GTC BIOTHERAPEUTICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The objective of this proposal is to produce tetraploid embryos for aggregation with nuclear transfer embryos for the production of transgenic cattle and goats. GTC Biotherapeutics (formerly Genzyme Transgenics Corporation) has developed the expression of recombinant proteins in the milk of transgenic dairy animals. The milk of transgenic goats and cattle is a ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. TARGETING 4.5S RNA ANTIMIRCOBIAL DRUG DISCOVERY

    SBC: IBIS BIOSCIENCES, INC.            Topic: N/A

    N/A

    STTR Phase I 1999 Department of Health and Human Services
  9. Combinatorial Carbohydrate Libraries for Drug Discovery

    SBC: IBIS BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Development of new antimicrobial compounds is urgently needed as bacteria evolve resistance to the antibiotics of last resort. The long-term objective of this proposal is to identify new carbohydrate-based compounds that bind to the small ribosomal subunit and specifically alter bacterial translation. Five hundred new a ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  10. Homogeneous Mutation Scanning

    SBC: IDAHO TECHNOLOGY            Topic: N/A

    DESCRIPTION (provided by applicant): Our objective is to provide a homogeneous, closed-tube system for DNA mutation scanning on a high-throughput platform. For many complex genetic diseases, it is very difficult and expensive to screen for all possible mutations that may cause the disease. We propose a relatively simple solution. Certain dyes are compatible with PCR and can detect sequence alterat ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government